News & Media

Swiss Rockets Collaborates with Lonza to Advance Torqur’s Oncology Drug Candidate Bimiralisib into Late-Stage Clinical Development

Swiss Rockets AG Appoints Prof. Dr. Andreas Türler as Chief Radiochemist

Complete Genomics Highlights DNBSEQ-T7+ at AGBT 2026, Expanding High-Throughput Sequencing Capability

A Defining Milestone for Swiss Rockets and Complete Genomics

CoolMPS™ 600: Accurate and Affordable Long MPS/NGS Reads on a Mid-Throughput Platform

Complete Genomics Enters Definitive Agreement to Be Acquired by Swiss Rockets AG

Swiss Rockets Appoints former Roche Senior Executive Tiffany Payette as Chief Corporate Affairs and Investor Relations Officer

Swiss Rockets AG Sponsored and Participated with an Exhibition Booth at the 8th Theranostics World Congress 2026 in Cape Town

Swiss Rockets AG to Sponsor and Participate with an Exhibition Booth at the 8th Theranostics World Congress 2026 in Cape Town

Swiss Rockets Group and Alloy Therapeutics Partner to Advance Radioligand Therapeutics in Oncology

Story of knowledge that knows no boundaries

Swiss Rockets Announces Strategic Exclusive License Acquisition of Cutting-Edge Sequencing Technology from MGI Tech and Complete Genomics

Swiss Rockets and Squirro Announce Strategic Partnership to Accelerate AI Transformation in Biotechnology

Swiss Rockets Serbia Signs Joint Declaration of Intent with European Commission and Development Agency of Serbia to Establish Regional Centre of Excellence for Precision Medicine

Swiss Rockets Signs Strategic Exclusive Licensing Agreement with MGI and Complete Genomics, Subject to MGI Shareholder Approval